Literature DB >> 17649796

Tumor markers in pleural effusions.

O Topolcan1, L Holubec, V Polivkova, S Svobodova, M Pesek, V Treska, J Safranek, T Hajek, L Bartunek, M Rousarova, J Finek.   

Abstract

AIM: The aim of this study was to determine the diagnostic capabilities of tumor markers in pleural effusion and their importance for assessment of the etiology of pleural effusions. PATIENTS AND METHODS: In pleural effusions from 166 patients hospitalized during the period 2003-2005 at the Department of Oncology and Radiotherapy, Faculty Hospital in Pilsen, the following tumor markers were determined: thymidine kinase (TK), neuron-specific enolase (NSE), cytokeratins [tissue polypeptide antigen (TPA), tissue polypeptide-specific antigen (TPS) and cytokeratin fragment 19 (CYFRA 21-1)], carcinoembryonic antigen (CEA) and mucinous markers (CA 15-3, CA 19-9, CA 125). The inflammatory marker procalcitonin-PCT was also assessed.
RESULTS: Tumor markers CA 125, TPA, TPS were significantly elevated in exudates, irrespective of the etiology, as a non-specific reaction in mesothelial cells. TK had a sensitivity of over 80% for all the types of cancer examined, while CA 15-3 had a sensitivity of over 90%.
CONCLUSION: Significant positivity of PCT and CA 15-3 in pleural effusions indicate a suspicion of inflammatory disease. Positivity of TK and CA 15-3 indicate a strong suspicion of malignant exudates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17649796

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Diagnostic value of procalcitonin in pleural effusions.

Authors:  C-Y Wang; Y-C Hsiao; J-S Jerng; C-C Ho; C-C Lai; C-J Yu; P-R Hsueh; P-C Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-10-13       Impact factor: 3.267

2.  Clinical diagnostic utility of CA 15-3 for the diagnosis of malignant pleural effusion: A meta-analysis.

Authors:  Qiang Wu; Min Li; Shu Zhang; Lu Chen; Xingting Gu; Feng Xu
Journal:  Exp Ther Med       Date:  2014-10-30       Impact factor: 2.447

3.  [Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion].

Authors:  Hongmei Li; Junhua Fu; Yuande Xiu; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-06

4.  [Diagnotic value of the combined determination of telomerase activity in induced sputum, pleural effusion and fiberobronchoscopic biopsy samples in lung cancer].

Authors:  Hongmei Li; Feng Hua; Cheng Zhao; Guangzhen Liu; Qinghua Zhou
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-02

5.  Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion.

Authors:  Klaus Hackner; Peter Errhalt; Sabin Handzhiev
Journal:  Ther Adv Med Oncol       Date:  2019-05-22       Impact factor: 8.168

6.  Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.

Authors:  Tian Tian; Jun Li; Wenjun Hu; Cuiling Sun; Jian Zhou
Journal:  J Clin Lab Anal       Date:  2019-04-15       Impact factor: 2.352

7.  Determination of the optimal volume of ascitic fluid for the precise diagnosis of malignant ascites.

Authors:  Feifei Zhang; Zhenning Feng; Yichi Zhang; Zishuai Liu; Xiaoli Sun; Shizhu Jin
Journal:  Saudi J Gastroenterol       Date:  2019 Sep-Oct       Impact factor: 2.485

8.  Cell-free miRNAs may indicate diagnosis and docetaxel sensitivity of tumor cells in malignant effusions.

Authors:  Li Xie; Xi Chen; Lifeng Wang; Xiaoping Qian; Tingting Wang; Jia Wei; Lixia Yu; Yitao Ding; Chenyu Zhang; Baorui Liu
Journal:  BMC Cancer       Date:  2010-10-28       Impact factor: 4.430

9.  Diagnostic Utility of Combined CEA, CA15-3 and CA125 Biomarkers and Cytomorphology in Suspicious and Malignant Serosal Fluid.

Authors:  Zahra Rahemi; Abdolreza Javadi; Behrang Kazeminejad; Abdolali Ebrahimi; Houman Vosough; Afsoon Taghavi; Shahriar Dabiri
Journal:  Iran J Pathol       Date:  2021-05-09

10.  Is neuron-specific enolase useful for diagnosing malignant pleural effusions? evidence from a validation study and meta-analysis.

Authors:  Jing Zhu; Mei Feng; Liqun Liang; Ni Zeng; Chun Wan; Ting Yang; Yongchun Shen; Fuqiang Wen
Journal:  BMC Cancer       Date:  2017-08-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.